Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-064907
Filing Date
2011-11-15
Accepted
2011-11-15 12:07:30
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v239529_10q.htm 10-Q 612783
2 EXHIBIT 31.1 v239529_ex31-1.htm EX-31.1 18455
3 EXHIBIT 32.1 v239529_ex32-1.htm EX-32.1 10308
  Complete submission text file 0001144204-11-064907.txt   1664297

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nphc-20110930.xml EX-101.INS 150386
5 XBRL TAXONOMY EXTENSION SCHEMA nphc-20110930.xsd EX-101.SCH 11763
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nphc-20110930_cal.xml EX-101.CAL 13464
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nphc-20110930_def.xml EX-101.DEF 37521
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nphc-20110930_lab.xml EX-101.LAB 93089
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nphc-20110930_pre.xml EX-101.PRE 55276
Mailing Address 2776 UNIVERSITY DRIVE CORAL SPRINGS, FL 33065
Business Address 2776 UNIVERSITY DRIVE CORAL SPRINGS, FL 33065 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

EIN.: 912021600 | State of Incorp.: CA
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 111206263
SIC: 2833 Medicinal Chemicals & Botanical Products